Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension ; volume:24 ; number:1 ; day:7 ; month:11 ; year:2023 ; pages:1-13 ; date:12.2023
Respiratory research ; 24, Heft 1 (7.11.2023), 1-13, 12.2023
- Creator
-
Mismetti, Valentine
Delavenne, Xavier
Montani, David
Bezzeghoud, Souad
Delezay, Olivier
Hodin, Sophie
Launay, David
Marchand-Adam, Sylvain
Nunes, Hilario
Ollier, Edouard
Reynaud-Gaubert, Martine
Pastre, Jean
Traclet, Julie
Quetant, Sébastien
Zeghmar, Sabrina
Bertoletti, Laurent
Cottin, Vincent
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-023-02578-0
- URN
-
urn:nbn:de:101:1-2024012409131495946314
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mismetti, Valentine
- Delavenne, Xavier
- Montani, David
- Bezzeghoud, Souad
- Delezay, Olivier
- Hodin, Sophie
- Launay, David
- Marchand-Adam, Sylvain
- Nunes, Hilario
- Ollier, Edouard
- Reynaud-Gaubert, Martine
- Pastre, Jean
- Traclet, Julie
- Quetant, Sébastien
- Zeghmar, Sabrina
- Bertoletti, Laurent
- Cottin, Vincent
- SpringerLink (Online service)
Other Objects (12)
Enrichr in silico analysis of MS-based extracted candidate proteomic biomarkers highlights pathogenic pathways in systemic sclerosis
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers
Idiopathic portal hypertension complicating systemic sclerosis: a case report
Biomarkers inform clinical trials and pathogenesis in systemic sclerosis
Sirtuin3 and Sirtuin7 are promising biomarkers in systemic sclerosis
Biomarkers in the evaluation of cardiac involvement in systemic sclerosis
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Early treatment of borderline pulmonary arterial hypertension associated with systemic sclerosis
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Biomarkers of systemic inflammation in farmers with musculoskeletal disorders; a plasma proteomic study
Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development
The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia
Enrichr in silico analysis of MS-based extracted candidate proteomic biomarkers highlights pathogenic pathways in systemic sclerosis
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers
Idiopathic portal hypertension complicating systemic sclerosis: a case report
Biomarkers inform clinical trials and pathogenesis in systemic sclerosis
Sirtuin3 and Sirtuin7 are promising biomarkers in systemic sclerosis
Biomarkers in the evaluation of cardiac involvement in systemic sclerosis
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Early treatment of borderline pulmonary arterial hypertension associated with systemic sclerosis
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Biomarkers of systemic inflammation in farmers with musculoskeletal disorders; a plasma proteomic study
Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development
The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia
Enrichr in silico analysis of MS-based extracted candidate proteomic biomarkers highlights pathogenic pathways in systemic sclerosis
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers
Idiopathic portal hypertension complicating systemic sclerosis: a case report
Biomarkers inform clinical trials and pathogenesis in systemic sclerosis
Sirtuin3 and Sirtuin7 are promising biomarkers in systemic sclerosis
Biomarkers in the evaluation of cardiac involvement in systemic sclerosis
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Early treatment of borderline pulmonary arterial hypertension associated with systemic sclerosis
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Biomarkers of systemic inflammation in farmers with musculoskeletal disorders; a plasma proteomic study
Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development